98%
921
2 minutes
20
Although the mechanism for the occurrence of acute myocardial infarction (MI) has been investigated by many pathological and clinical studies, it has not been adequately clarified yet. Although the disruption of vulnerable plaque is a well-known cause of acute MI, there are many silent plaque disruptions detected in the coronary artery by intravascular imaging studies. Therefore, many vulnerable plaques may disrupt and heal without causing acute MI. Some additional mechanisms other than the disruption of vulnerable plaque would be essential for the onset of acute MI. On the other hand, blood thrombogenicity would change dynamically due to circadian rhythms and many other factors. The combination of plaque and blood thrombogenicity would play an important and determinant role for the onset of acute MI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jjcc.2020.08.007 | DOI Listing |
Background Gestational diabetes mellitus (GDM) has been increasingly associated with heightened cardiovascular and thrombotic risk. This study aimed to evaluate hemostatic and metabolic profiles in women with GDM to explore early markers of vascular dysfunction. Methods A retrospective cross-sectional study was conducted among 250 pregnant women diagnosed with GDM between December 2022 and October 2023 at multiple tertiary healthcare facilities in Pakistan.
View Article and Find Full Text PDFActa Biomater
August 2025
Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty, RWTH Aachen University, Germany. Electronic address:
Background: Reliable in-vitro thrombogenicity testing of medical devices requires large blood volumes, which cannot be obtained from humans. Slaughterhouse blood is an ethically acceptable, cost-effective alternative. While porcine blood is already used in hemolysis testing, its use for thrombogenicity testing remains limited regarding its comparability to human blood.
View Article and Find Full Text PDFCancers (Basel)
August 2025
Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.
(1) Background: The presence of metastatic disease significantly increases the risk of venous thromboembolism (VTE) in breast cancer, particularly during chemotherapy. Although not categorized as a highly thrombogenic malignancy, the elevated global prevalence of this cancer places a substantial number of patients at risk of thrombosis, which cannot yet be accurately predicted by validated risk assessment models (RAMs), highlighting the need for a dedicated model. (2) Aim: This study aims to develop a RAM for VTE in newly diagnosed metastatic breast cancer patients enrolled in a prospective, observational, and multicenter study.
View Article and Find Full Text PDFFront Bioeng Biotechnol
August 2025
Laboratory of Human Anatomy, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Introduction: Current hemostatic agents face several limitations, including reduced effectiveness in controlling massive bleeding or preventing thrombogenic events. Functional bleeding control could allow time for further treatment and decrease mortality rates. Using suitable hemostatic agents may improve surgical outcomes by eliminating avoidable complications.
View Article and Find Full Text PDFASAIO J
August 2025
From the FLOW, Department of Engineering Mechanics, Royal Institute of Technology (KTH), Stockholm, Sweden.
Thrombosis in extracorporeal membrane oxygenation (ECMO) circuit components remains a challenge. Besides blood state and surface properties, flow plays a critical role in hemostasis. In this work, we aimed to study the fluid dynamics of a membrane lung (ML) outlet due to its complex design with pins protruding into the blood flow stream (temperature sensor and cap of purge line), with respect to the potential risk of flow-induced coagulation activation.
View Article and Find Full Text PDF